Análisis de marcadores biológicos en el Proyecto Estratégico de Cáncer de Pulmón CIBERES-RTIC Cáncer-SEPAR

Monsó, Eduard; Montuenga, Luis M; Sánchez de Cos, Julio; Villena, Cristina.
Arch. bronconeumol. (Ed. impr.) ; 51(9): 462-467, sept. 2015. ilus
Artículo en Español | IBECS (España) | ID: ibc-144095

Documentos relacionados

  1. Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
  2. Lung-cancer researchers and clinicians must pay more attention to women.
  3. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.
  4. Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes.
  5. The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.
  6. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy.
  7. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
  8. Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden.
  9. Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non-Small Cell Lung Cancer in U.S. Community Medical Centers.
  10. Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study.